Smallwood Wealth Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5K Hold
71
0.01% 307
2026
Q1
$14K Sell
71
-1
-1% -$193 0.01% 294
2025
Q4
$13.1K Hold
72
0.01% 290
2025
Q3
$11K Sell
72
-3
-4% -$454 0.01% 313
2025
Q2
$10.4K Sell
75
-67
-47% -$9.39K 0.01% 316
2025
Q1
$20.8K Buy
+142
New +$20.5K 0.01% 254

Other funds holding AZN

Smallwood Wealth Investment Management's AZN Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 71 shares worth $13.5K. The position accounts for 0.01% of the portfolio, ranked #307.

Smallwood Wealth Investment Management first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $20.8K in Q1 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Smallwood Wealth Investment Management held 71 shares of AstraZeneca worth $13.5K as of Q2 2026.
  • Smallwood Wealth Investment Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #307 holding.
  • Smallwood Wealth Investment Management first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
  • Smallwood Wealth Investment Management's AstraZeneca position peaked at $20.8K in Q1 2025.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.